Pneumococcal Vaccine Recommendation
Journal: Annals of Internal Medicine (1982)

Diagnosis and Treatment1 February 1982Pneumococcal Vaccine RecommendationAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-96-2-206 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail AbstractAbstractVaccination with the now-available pneumococcal vaccine is recommended for persons with diseases and other conditions predisposing to the development of bacteremic pneumococcal pneumonia or increased risk of death from such infection. The value of vaccination on the basis of advanced age is not clear at this time. The vaccine will not eliminate all risk of pneumococcal pneumonia and patients with some immune deficiency states may not respond adequately to the vaccine. Revaccination should not be done at intervals of less than five years. More data are needed from adequately designed and executed studies of benefit from the vaccine in healthy elderly persons and high-risk populations. Physicians should pay particular attention to specific diagnostic needs in pneumococcal infection. This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Members of the Medical Practice Committee for the 1981-1982 term are as follows: Edwin P. Maynard. III. M.D.; Chairman; Adrian L. Edwards, M.D.; John M. Eisenberg. M.D.; Robert V. Elliot M.D.; Herbert C. Flessa, M.D.; Christopher C. Fordham III. M.D.; John R. Gamble M.D.; Paul F. Griner, M.D.; Virgil Loeb, Jr . M.D., Frank G. MacMurray M.D.; James R. McPherson. M. D.; James M Moss. M.D.; Donald E. Olson, M.D.; Seymour Perry, M.D.; Malcolm L. Peterson. M.D.; Albert D Robert. Jr., M.D.; Fenton Schaffner, M.D.; Helen Smits M.D.; Donald M. Switz, M.D.▸ From the American College of Physicians; Philadelphia. Pennsylvania. The analysis leading to these recommendations was developed by the Clinical Efficacy Assessment Project and the Medical Practice Committee, American College of Physicians. Philadelphia. Pennsylvania. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byRespiratory infections: Community-acquired pneumonia and newer microbesThe Protective Efficacy of Polyvalent Pneumococcal Polysaccharide VaccineAging, Immunity, and Critical Care NursingImmunizing the adultPneumococcal Vaccine and Patients with Chronic Lung DiseaseJAMES H. WILLIAMS Jr., M.D., KENNETH M. MOSER, M.D.Immune Function, Autoimmunity, and Selective Immunoprophylaxis in the AgedPneumococcal Vaccination: The Response of Patients with Alcoholic Liver CirrhosisEpidemiology of IllnessImmunization Against Infectious Diseases: Practice and ProblemsSafety, Efficacy, and Effectiveness of Clinical Practices: A New InitiativeJ. SANFORD SCHWARTZ, M.D., JOHN R. BALL, M.D., J.D., ROBERT H. MOSER, M.D. 1 February 1982Volume 96, Issue 2Page: 206-207KeywordsElderlyImmune deficiencyInfectious diseasesPneumoniaPopulation statisticsVaccines ePublished: 1 December 2008 Issue Published: 1 February 1982 Copyright & Permissions© 1982 American College of PhysiciansPDF downloadLoading ...